David Kuo - Concepedia

Author

David Kuo

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Chen, Ping, D. KUO, D. Kuo, D. W. Kuo, D.W. Kuo, David Kuo, David W. Kuo, Kuo, David

Publications

454

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Case Western Reserve University

About

David Kuo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in natural sciences, chemical biology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	7	7	224
2	Biochemistry	6	6	199
3	Medicine	4	4	104
4	Engineering	2	2	79
5	Biomolecular Engineering	2	2	101

David Kuo

Publications

454

Citations

H-Index

Page 1

	Year	Citations
Escherichia coli Leader Peptidase: Production of an Active Form Lacking a Requirement for Detergent and Development of Peptide Substrates David Kuo, Hak‐Kim Chan, Carol J. Wilson, Archives of Biochemistry and Biophysics Active FormPeptoidPeptide SynthesisPeptide SubstratesMicrobiology	1993	65
Specificity, stability, and potency of monocyclic .beta.-lactam inhibitors of human leukocyte elastase Wilson B. Knight, B. G. Green, Renee M. Chabin, Biochemistry	1992	55
Determination of the Kinetic Parameters of Escherichia coli Leader Peptidase Activity Using a Continuous Assay: The pH Dependence and Time-Dependent Inhibition by .beta.-Lactams Are Consistent with a Novel Serine Protease Mechanism David Kuo, Jeffrey R. Weidner, Patrick R. Griffin, Biochemistry Lpase ReactionContinuous AssayBacteriologyChemical BiologyShort Form	1994	49
Novel Quorum-Quenching Agents Promote Methicillin-Resistant Staphylococcus aureus (MRSA) Wound Healing and Sensitize MRSA to β-Lactam Antibiotics David Kuo, Guan-Ping Yu, Wyatt B. Hoch, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantSensitize MrsaAntimicrobial ChemotherapyDrug ResistanceAntimicrobial Stewardship	2014	45
Preparative Enzymatic Synthesis and Characterization of the Cytoplasmic Intermediates of Murein Biosynthesis Sreelatha G. Reddy, Sherman T. Waddell, David Kuo, Journal of the American Chemical Society BiosynthesisEngineeringBiotransformationBiochemistryCellular Enzymology	1999	43
Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens Michael E. Greenberg, David Kuo, Eckhard Jankowsky, Scientific Reports	2018	42
Phosphinic acid inhibitors of matrix metalloproteinases Charles G. Caldwell, Soumya P. Sahoo, Scott A. Polo, Bioorganic & Medicinal Chemistry Letters BiochemistryNatural SciencesMetalloproteinPhosphinic Acid InhibitorsChemical Biology	1996	37
Engineering a Cell-Free Murein Biosynthetic Pathway: Combinatorial Enzymology in Drug Discovery Kenny K. Wong, David Kuo, Renee M. Chabin, Journal of the American Chemical Society EngineeringCombinatorial EnzymologyAltmetric Attention ScoreMolecular BiologyChemical Biology	1998	36
Inhibition of stromelysin-1 (MMP-3) by peptidyl phosphinic acids Joung L. Goulet, Joanne F. Kinneary, Philippe L. Durette, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNatural SciencesChemical BiologyPharmacology	1994	25
Combinatorial Synthesis and in Vitro Evaluation of a Biaryl Hydroxyketone Library as Antivirulence Agents against MRSA Guan-Ping Yu, David Kuo, Menachem Shoham, ACS Combinatorial Science	2013	23

Page 1